AccuBio

Effective point-of-collection substance misuse testing relies on two key elements, rapid screening and secure sample collection for confirmatory laboratory analysis. AccuBio’s drugs of abuse range supports both.

✅Single or multi-drug panel tests
✅Urine and oral fluid sample tests
✅Secure sample collection and transport devices

Learn more: https://www.accubio.co.uk/products/toxicology/urine

Metabolic health is recognised as a key driver of long-term health outcomes, with greater focus on early intervention, prevention and personalised healthcare.

AccuBio’s rapid FIA metabolism range quantitatively measures biomarkers that assess metabolic function to support patient management.

Delivering laboratory-quality performance closer to the patient, AccuBio’s FIA platform provides actionable results, supporting the shift towards preventative and personalised healthcare.

Contact Us: https://www.accubio.co.uk/contact.html

Respiratory virus season can place significant pressure on healthcare services.

Planning ahead, can ensure organisations have the right diagnostic tests, to meet demand, before the season starts.

AccuBio's respiratory virus test menu includes individual and combination lateral flow tests for both self-testing and point-of-care use.

Learn more: https://www.accubio.co.uk/products/infectiousdisease/respiratory/FluAB_COVID-19_RSV

AccuBio's CLIA-go Pro brings laboratory-quality chemiluminescence immunoassay testing to near-patient and decentralised healthcare settings.

✅ Results in 15 minutes
✅ Walkaway operation
✅ Comprehensive (40+) test menu
✅ LIS connectivity

Informed clinical decision-making, closer to the patient.

Learn more: https://www.accubio.co.uk/products/analysers/CLIA